Liabooks Home|PRISM News
PRISM

#Biotech

Total 4 articles

AstraZeneca's $100M Bet Shows China's Pharma Industry Is Flipping the Script
TechEN
AstraZeneca's $100M Bet Shows China's Pharma Industry Is Flipping the Script

AstraZeneca's $100 million upfront payment to China's Jacobio Pharma for a novel drug signals a major shift. The deal shows China's evolution from a generics maker to a key source of pharma innovation.

9 Biotech Startups Vying for $100K That Could Redefine Medicine
TechEN
9 Biotech Startups Vying for $100K That Could Redefine Medicine

Meet 9 innovative biotech startups from TechCrunch's Startup Battlefield 200. Discover the technologies set to change the future of medicine, from CRISPR gene editing to AI diagnostics and nanotechnology.

Beyond the Breakthroughs: MIT Tech Review Preps Its List of 2025's 'Worst Technologies'
TechEN
Beyond the Breakthroughs: MIT Tech Review Preps Its List of 2025's 'Worst Technologies'

2025 saw major leaps in AI and biotech. But what about the failures? MIT Technology Review is set to reveal its annual list of the year's worst technologies, offering a critical look at what went wrong.

The Pharma Paradox: Why Big Pharma's $171B Patent Cliff Leads Straight to China
EconomyEN
The Pharma Paradox: Why Big Pharma's $171B Patent Cliff Leads Straight to China

Big Pharma faces a $171B revenue cliff. Their solution? Chinese biotech. Our analysis unpacks the high-stakes clash between economic need and geopolitical risk.